SMAD1 and ocular melanoma: At day 21, RA treatment exhibited the highest phosphorylated Smad1/5/8 level, followed by OM and BMP-2 (ρ<0.001), while no expression was observed in the BMP-2+RA and MC3T3-E1 groups.